SS

Sudhir Singh

Active Director Director DIN 01085962
DIN 01085962 First appointment Dec 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 1996
Shareholding value •••• Premium profile

About Sudhir Singh

Data last updated:

Sudhir Singh is a Director at Rescure Remedies Private Limited (since 1996). The company operates in Pharma. Rescure Remedies Private Limited reported revenue of ₹42,630 (FY 2025).

DIN 01085962
Primary Designation Director
Industry Pharma
First Appointment 12 Dec 1996
Oldest Company Age 29 yrs
Largest company Rescure Remedies Private Limited · ₹42,630 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rescure Remedies Private Limited U24231CH1996PTC019148
Director12 Dec 19961996₹42,630 (FY 2025)Active

Board colleagues of Sudhir Singh

NameDINCompanyDesignation
Seema Singh Saini00931155Rescure Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rescure Remedies Private Limited
Premium access

Shareholding and investment profile for Sudhir Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Singh

Sudhir Singh currently holds 1 directorship: Rescure Remedies Private Limited (Director, since 12 Dec 1996, revenue ₹42,630 (FY 2025)).

Sudhir Singh was first appointed on 12 Dec 1996 as Director at Rescure Remedies Private Limited.

The current boards of Sudhir Singh's companies include Seema Singh Saini (Rescure Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available